Molecular Templates to Participate in Upcoming Virtual Investor Conferences

Rhea-AI Summary

Molecular Templates (Nasdaq: MTEM) announced its participation in three major healthcare conferences: the Cowen 41st Annual Health Care Conference, Barclays Global Healthcare Conference, and Oppenheimer 31st Annual Healthcare Conference. The Cowen conference is scheduled for March 1-4, with a presentation on March 4 at 11:10 AM ET. The Barclays conference runs from March 9-11, featuring a presentation on March 10 at 3:00 PM ET. The Oppenheimer conference takes place March 16-17, with a presentation on March 17 at 11:20 AM ET. Webcasts will be accessible via MTEM's website.

AUSTIN, Texas, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, today announced that it will present and participate in 1-on-1 investor meetings at the Cowen 41^st Annual Health Care Conference, the Barclays Global Healthcare Conference and the Oppenheimer 31^st Annual Healthcare Conference.

Cowen 41^st Annual Health Care Conference
Conference Dates: March 1-4
Presentation Date and Time: Thursday, March 4^th at 11:10 AM ET
        
Barclays Global Healthcare Conference
Conference Dates: March 9-11
Presentation Date and Time: Wednesday, March 10^th at 3:00 PM ET

Oppenheimer 31^st Annual Healthcare Conference
Conference Dates: March 16-17
Presentation Date and Time: Wednesday, March 17^th at 11:20 AM ET         

Live webcasts of these presentations will be available in the “News and Events” section of the MTEM website at www.mtem.com. Additionally, replays of the webcasts will be available on the corporate website following the conferences. 

About Molecular Templates  
Molecular Templates is a clinical-stage company focused on the discovery and development of targeted biologic therapeutics. Our proprietary drug platform technology, known as engineered toxin bodies, or ETBs, leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer and other serious diseases.

Investor Contact:
Adam Cutler
Chief Financial Officer
adam.cutler@mtem.com
862-204-4006

Source: Molecular Templates, Inc.

FAQ

What are the dates for the Cowen 41st Annual Health Care Conference where MTEM will present?

The Cowen 41st Annual Health Care Conference will take place from March 1-4, 2021, with Molecular Templates presenting on March 4 at 11:10 AM ET.

When will MTEM present at the Barclays Global Healthcare Conference?

Molecular Templates will present at the Barclays Global Healthcare Conference on March 10, 2021, at 3:00 PM ET.

What is the schedule for the Oppenheimer 31st Annual Healthcare Conference for MTEM?

MTEM will present at the Oppenheimer 31st Annual Healthcare Conference on March 17, 2021, at 11:20 AM ET.

Where can I watch the presentations for MTEM at these conferences?

Live webcasts of MTEM's presentations will be available in the 'News and Events' section of their website at www.mtem.com.

What is the focus of Molecular Templates as a company?

Molecular Templates is focused on the discovery and development of engineered toxin bodies (ETBs) for cancer and other serious diseases.